Tag: Johnson & Johnson

December 7, 2015 Off

Johnson Johnson buys Novira Therapeutics

By Dino Mustafić

Johnson & Johnson has completed the acquisition of Novira Therapeutics, Inc., a privately held, clinical-stage biopharmaceutical company developing innovative therapies for curative treatment of chronic hepatitis B virus (HBV) infection.